Abstract | BACKGROUND AND OBJECTIVES: METHODS: RESULTS: In experiment one, 0.5 mg/m2 of cisplatin loaded in polymer resulted in a mean survival time (MST) of 51 +/- 14 days with 63% (10/16) rats surviving to day 60. MST for the control group was 24 +/- 4 days (p = 2.5 x 10(-9)). Evidence of clinical or histologic brain toxicity was minimal. In a second experiment, using drug-free polymer (n = 7), MST was 24 +/- 3 days. This was compared against an MST of 24 +/- 4 days in the tumor control group (n = 7) and 49 +/- 7 days in a cisplatin- polymer treated group (n = 6). In a third experiment, two doses of drug-free polymer and three doses of cisplatin-loaded polymer were tested in normal nontumor-bearing rats and found to be well tolerated. CONCLUSIONS: Intralesional sustained release of cisplatin from biodegradable polymer is safe and effective for the treatment of brain 9L gliosarcoma in rats.
|
Authors | Q Kong, B K Kleinschmidt-Demasters, K O Lillehei |
Journal | Journal of surgical oncology
(J Surg Oncol)
Vol. 64
Issue 4
Pg. 268-73
(Apr 1997)
ISSN: 0022-4790 [Print] United States |
PMID | 9142181
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Delayed-Action Preparations
- Drug Implants
- Polyesters
- Polymers
- Lactic Acid
- poly(lactide)
- Cisplatin
|
Topics |
- Animals
- Brain Neoplasms
(drug therapy, pathology)
- Cisplatin
(administration & dosage)
- Delayed-Action Preparations
- Drug Implants
- Gliosarcoma
(drug therapy, pathology)
- Lactic Acid
(administration & dosage)
- Male
- Neoplasm Transplantation
- Polyesters
- Polymers
(administration & dosage)
- Rats
- Rats, Inbred F344
- Survival Analysis
|